The $75 figure is not an official published consensus; it is a calculated average. Several analysts revised their price targets shortly after the company's latest quarterly report in early November 2026, and those recent, identifiable targets cluster between roughly $55 and $98. Among them, Needham cut its target to $55, Freedom Capital Markets to $65, B. Riley Securities to $70, Oppenheimer held a neutral stance near $80, and Stifel retained a Buy with a $93 target. Averaging these recent figures produces approximately $73, which rounds to the $75 headline target.
The wide spread matters more than the headline number. The most cautious analysts point to near-term execution risk, margin pressure, and a valuation multiple that has already compressed sharply, while the more bullish argue the earnings trajectory supports meaningful upside. Broader aggregator data suggests roughly eight analysts cover the stock, with an average target near $75 and a high end extending toward $98. Notably, nearly all of these targets were cut after the latest results, meaning the Street is trimming expectations even as it keeps mostly Buy ratings. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The shares closed near $31 in early November 2026, down sharply from a 52-week high of about $114 and well above the 52-week low near $14. Reaching $75 from this level implies roughly 142% upside, which must be described as a very large move rather than a modest or even a substantial one. The path would require a sustained re-rating of the stock alongside fundamental improvement, not merely a technical bounce.
The company reported roughly $329 million of quarterly revenue and a profit of about $0.54 per share that handily exceeded expectations. Analysts currently model revenue of around $1.65 billion and EPS near $2.65 for 2027, a dramatic acceleration from recent results. That kind of earnings growth, if realized, is the mechanical foundation on which a move toward $75 would rest, but the gap between today's price and the target means the market would need to grow more confident in the durability of that recovery.
The most credible support comes from the earnings outlook. A better-than-forecast quarterly profit, combined with consensus estimates for substantial revenue and profit growth into 2027, underpins the bullish case. Ichor is leveraged to the semiconductor equipment cycle, and a recovery in memory and logic spending by its large OEM customers would flow directly into demand for its gas and chemical delivery subsystems. The company's forward P/E ratio looks inexpensive relative to the modeled earnings recovery, which is a key argument some analysts make for significant upside from current levels.
The obstacles are considerable. First, the move required is very large, and the stock has already demonstrated extreme volatility in both directions. Second, analysts cut their targets after the latest report, signaling that near-term execution, order timing, and margin concerns weigh on the valuation even where earnings beat. Third, Ichor's revenue is concentrated among a small number of large OEM customers, so a slowdown at any major customer could quickly reset demand. Finally, margin pressure and the possibility that the semiconductor cycle softens again could compress the multiple investors are willing to pay, keeping the shares far below $75 for an extended period.
The stock's technical structure reflects a steep decline rather than a base of support. Having traded near $114 earlier in the year, the shares fell through multiple prior levels to settle near $31. The 52-week low near $14 represents a distant downside reference point, while the recent trading range in the high $20s to low $30s now acts as the immediate zone to watch. A durable recovery toward $75 would first need to reclaim a series of prior breakdown levels well above the current price, meaning the technical picture currently favors caution even if the fundamental long-term story has appeal.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual analysts vary and none of the figures here should be read as a guarantee or a timing forecast. Investors should monitor the company's next earnings reports and guidance, any further analyst target revisions, gross margin trends, order activity from large OEM customers, and the broader semiconductor capital equipment cycle. Changes in memory and logic spending, along with interest-rate decisions that affect capital-intensive chipmaking investment, are also relevant.
From what I see, tools like Tickeron's AI Daily Buy/Sell Signals provide a practical way to stay on top of volatile names such as Ichor Holdings. These signals draw on artificial intelligence to scan thousands of stocks and ETFs in real time, delivering Buy, Sell, or Hold indications based on technical patterns and shifting market conditions. In my view, this kind of automated oversight can complement traditional analysis when tracking a stock with such a wide price history and uncertain near-term path.
The $75 target reflects an average of recent analyst price targets that ranges from about $55 to $98, implying a very large move of roughly 142% from the current price near $31. The bullish case rests on a genuine earnings inflection and a semiconductor equipment recovery, while the bearish case emphasizes the size of the required move, recently reduced targets, customer concentration, and margin risk. There is no guarantee the stock reaches $75, and the wide analyst range shows how divided opinion remains. Investors should watch earnings guidance, target revisions, and the broader chip-equipment cycle for the next signals.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
Following a +13.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in 253 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICHR as a result. In 72 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 38 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.
ICHR moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ICHR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 88%.
The 50-day moving average for ICHR moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for ICHR entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.340) is normal, around the industry mean (5.670). P/E Ratio (-26.466) is within average values for comparable stocks, (68.795). Projected Growth (PEG Ratio) (0.251) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.761) is also within normal values, averaging (27.897).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. ICHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment
Industry ElectronicProductionEquipment